Microfluidic, Medical Innovation, Organs On Chips, Microfluidic Engineering, New Drug Approval.
Development costs at 10–25 percent. They looked at costs by phase. They concluded that organ-on-chip technology could significantly reduce costs by reducing the length of the early-stage research phase: “Experts believed that the technology will help to make quicker and more precise decisions”